Third Quarter 2022 Financial Highlights:

• Revenue of $439.3 million, an increase of 18.8% compared to the prior year period; organic revenue growth of 9.2%
• Net income of $17.6 million, an increase of 33.3% compared to the prior year period
• Adjusted EBITDA of $77.0 million, an increase of 16.3% compared to the prior year period

PITTSBURGH -- Evoqua Water Technologies (NYSE:AQUA), an industry leader in mission-critical water treatment solutions, today reported results for its third quarter ended June 30, 2022. 

Revenue for the third quarter of fiscal year 2022 was $439.3 million, compared to $369.7 million in the prior year period, an increase of 18.8%, or $69.6 million. Organic revenue grew 9.2%, or $34.1 million, driven by favorable price realization and higher volume for products and services across most product lines and all regions. ; Inorganic revenue contributed $40.8 million related to our acquisition of the Mar Cor business on January 3, 2022. Revenue was unfavorably impacted by $5.3 million in the period related to foreign currency translation.  Net income for the quarter was $17.6 million, resulting in diluted earnings per share (“EPS”) of $0.14, as compared to net income of $13.2 million and diluted EPS of $0.11 in the prior year period. The increase in net income of 33.3%, or $4.4 million, was driven by higher revenue and related gross profit. The increase was partially offset by increased expenses primarily related to foreign currency translation losses in the current period, compared to foreign currency translation gains in the prior period, mostly related to intercompany loans, as well as increased costs associated with recent acquisitions and inflation.  Adjusted EBITDA for the quarter was $77.0 million, as compared to $66.2 million in the prior year period, an increase of 16.3%, or $10.8 million.  See the “Use of Non-GAAP Measures” section below for additional information regarding adjusted EBITDA and organic revenue.

“We were very pleased with our third quarter results, particularly given challenging market dynamics. Global demand remains strong with growth across all regions driving organic revenues up over 9% in the quarter.  Our book to bill ratio was again over 1.0, driven by strong capital, aftermarket, and service orders. Price/cost was positive for the quarter and year-to-date, as we continue to actively manage challenges in our supply chain and inflationary costs. Cash flow improved for the quarter, with operating cash flow up 45% from the prior year quarter, and our balance sheet continues to remain strong, with liquidity and net debt leverage both improving sequentially from the second quarter.”

Mr. Keating continued, “We continue to invest in the business to support long term growth and we welcome our new colleagues from Smith Engineering and Epicor, two acquisitions announced in July. We also opened global manufacturing facilities in the United Kingdom and Singapore to support our international growth and expanding footprint. The integration of Mar Cor continues to be on track, and we reiterate our expectation for Mar Cor to achieve 25% adjusted EBITDA margin in the next 12-18 months.”

Mr. Keating closed, “Heading into the final quarter of our fiscal year, we continue to execute on our strategy and are managing conversion of our strong backlog. Labor and material constraints remain, and we are navigating global supply chain challenges and our customers’ readiness for delivery. I am very proud of our team’s performance during these turbulent market conditions. We are pleased to maintain our previously provided outlook for the fiscal year.”

A discussion of segment results can be found in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Results of Operations” within our Quarterly Report on Form 10-Q for the three months ended June 30, 2022.

 

Third Quarter Earnings Call and Webcast

The Company will hold its third quarter fiscal 2022 earnings conference call Tuesday, August 2, 2022, at 10:00 a.m. E.T.  The live audio webcast and presentation slides for the call will be accessible via Evoqua’s Investor Relations website, //aqua.0or9.cn/.

Participant Details
Dial-In Numbers:
Toll Free US:     800-459-5346
International:   +1 203-518-9544
Conference ID:  AQUAQ3

The link to the webcast replay as well as the presentation slides will also be posted on Evoqua’s Investor Relations website.

Replay details:
Dial-In-Numbers:
US Toll Free Phone:   800-839-8328
International Phone: +1 402-220-6073
(Conference ID is not needed to access replay)

Replay available:  Beginning 1:00 p.m. E.T. on August 2 until 11:59 p.m. ET on August 16, 2022

 

Webcast Audience URL:

Dissemination of Company Information
The Company intends to make future announcements regarding developments and financial performance through the Investor Relations section of its website, //aqua.0or9.cn, as well as through press releases, filings with the Securities and Exchange Commission (the “SEC”), conference calls and webcasts.  The Company does not incorporate the information contained on, or accessible through, its corporate website into this press release.

About Evoqua Water Technologies
Evoqua Water Technologies is a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services, and expertise to support industrial, municipal and recreational customers who value water. Evoqua has worked to protect water, the environment and its employees for more than 100 years, earning a reputation for quality, safety and reliability around the world. Headquartered in Pittsburgh, Pennsylvania, the company operates in more than 150 locations across nine countries.  Serving more than 38,000 customers and 200,000 installations worldwide, our employees are united by a common purpose:  Transforming Water. Enriching Life.

Non-GAAP Financial Measures
This press release contains financial measures that are not calculated and presented in accordance with generally accepted accounting principles in the United States (“GAAP”), including adjusted EBITDA and organic revenue. These non-GAAP financial measures are provided as additional information for investors.  We believe these non-GAAP financial measures are helpful to management and investors in highlighting trends in our operating results and provide greater clarity and comparability period over period to management and our investors regarding the operational impact of long-term strategic decisions relating to capital structure, the tax jurisdictions in which we operate and capital investments. The presentation of this additional information is not meant to be considered in isolation or as a substitute for GAAP measures. For definitions of the non-GAAP financial measures used in this press release and reconciliations to the most directly comparable respective GAAP measures, see the “Use of Non-GAAP Measures” section below.

With respect to forward-looking guidance provided in this press release, we have not presented a quantitative reconciliation of the forward-looking non-GAAP financial measure adjusted EBITDA margin of the Mar Cor business to its most directly comparable GAAP financial measure because it is impractical to forecast certain items without unreasonable efforts due to the uncertainty and inherent difficulty of predicting the occurrence and financial impact of, and the periods in which, such items, including foreign exchange impact and certain expenses for which we adjust, may be recognized. For the same reasons, we are unable to address the probable significance of the unavailable information, which could be material to future results.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  You can generally identify forward-looking statements by our use of forward-looking terminology such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “goal,” “intend,” “may,” “might,” “plan,” “progress,” “potential,” “predict,” “projection,” “seek,” “should,” “will,” or “would” or the negative thereof or other variations thereon or comparable terminology.  All of these forward-looking statements are based on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements, or could affect our share price. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, among other things, general global economic and business conditions, including the impacts of the COVID-19 pandemic, geopolitical conflicts, such as the conflict between Russia and Ukraine, and potential recessionary conditions; our ability to execute projects on budget and on schedule; material, freight, and labor inflation, commodity and component availability constraints, and disruptions in global supply chains and transportation services; the potential for us to incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees; our ability to meet our own and our customers’ safety standards; failure to effectively treat emerging contaminants; our ability to continue to develop or acquire new products, services and solutions that allow us to compete successfully in our markets; our ability to implement our growth strategy, including acquisitions, and our ability to identify suitable acquisition targets; our ability to operate or integrate any acquired businesses, assets or product lines profitably; our ability to achieve the expected benefits of our restructuring actions; delays in enactment or repeals of environmental laws and regulations; the potential for us to become subject to claims relating to handling, storage, release or disposal of hazardous materials; our ability to retain our senior management, skilled technical, engineering, sales, and other key personnel and to attract and retain key talent in increasingly competitive labor markets; risks associated with international sales and operations; our ability to adequately protect our intellectual property from third-party infringement; risks related to our contracts with federal, state, and local governments, including risk of termination or modification prior to completion; risks associated with product defects and unanticipated or improper use of our products; our ability to accurately predict the timing of contract awards; risks related to our substantial indebtedness; our increasing dependence on the continuous and reliable operation of our information technology systems; risks related to foreign, federal, state and local environmental, health and safety laws and other applicable laws and regulations and the costs associated therewith; our ability to execute on our strategies related to environmental, social, and governance matters, and achieve related goals and targets, including as a result of evolving standards, laws, regulations, processes, and assumptions, delayed scientific and technological developments, increased costs, and changes in carbon markets; and other risks and uncertainties, including those listed under Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, as filed with the SEC on November 17, 2021, and in other filings we may make from time to time with the SEC.  All statements other than statements of historical fact included in this press release are forward-looking statements, including, but not limited to, expectations for the remainder of fiscal year 2022, expectations related to customer demand, our book to bill ratio, pricing initiatives, supply chain challenges, inflation, material and labor availability, and general macroeconomic conditions, and expectations with respect to the integration and performance of our recent acquisitions, including the realization of expected synergies. Any forward-looking statements made in this press release speak only as of the date of this release. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements made herein, whether as a result of new information, future events or otherwise after the date of this release.  These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this release.

 

 

EVOQUA WATER TECHNOLOGIES CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share amounts)

	Three Months Ended June 30,				Nine Months Ended June 30,
	2022		2021		2022		2021
Revenue from product sales and services.................................................................................................................	$    439,325		$    369,681		$ 1,232,321		$ 1,038,438
Cost of product sales and services.................................................................................................................	(303,193)		(252,652)		(856,795)		(720,145)
Gross profit.................................................................................................................	$    136,132		$    117,029		$    375,526		$    318,293
General and administrative expense.................................................................................................................	(61,426)		(50,837)		(186,231)		(146,048)
Sales and marketing expense.................................................................................................................	(40,634)		(35,871)		(116,942)		(103,629)
Research and development expense.................................................................................................................	         (3,857)		        (3,413)		(11,060)		;     (9,929)
Total operating expenses.................................................................................................................	$   (105,917)		$     (90,121)		$   (314,233)		$   (259,606)
Other operating income, net...............................................................................................................	         815		           1,402		3,597		     2,035
Income before interest expense and income taxes	$      31,030		$      28,310		$      64,890		$      60,722
Interest expense.................................................................................................................	      (8,440)		(11,224)		(24,969)		(28,292)
Income before income taxes...............................................................................................................	$      22,590		$      17,086		$      39,921		$      32,430
Income tax expense...............................................................................................................	    (5,027)		  (3,887)		  (8,896)		        (7,672)
Net income...............................................................................................................	$      17,563		$      13,199		$      31,025		$      24,758
Net income attributable to non‑controlling interest...............................................................................................................	;             —		   44		        ;    145		            134
Net income attributable to Evoqua Water Technologies Corp................................................................................................................	$      17,563		$      13,155		$      30,880		$      24,624
Basic income per common share...................................................................................................................	$           0.14		$           0.11		$           0.26		$           0.21
Diluted income per common share...................................................................................................................	$           0.14		$           0.11		$        ;   0.25		$           0.20

 

 

EVOQUA WATER TECHNOLOGIES CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

	(Unaudited)
	June 30, 2022		September 30, 2021
ASSETS
Current assets...........................................................................................................................................................	$       832,220		$       678,458
Cash and cash equivalents......................................................................................................................................................	      137,839		;        146,244
Receivables, net......................................................................................................................................................	     293,471		      277,995
Inventories, net......................................................................................................................................................	      232,459		 158,503
Contract assets......................................................................................................................................................	101,899		;          72,746
Other current assets......................................................................................................................................................	           66,552		          22,970
Property, plant, and equipment, net...........................................................................................................................................................	    400,367		     374,988
Goodwill...........................................................................................................................................................	     471,688		; ;      407,376
Intangible assets, net...........................................................................................................................................................	       315,983		   290,075
Operating lease right-of-use assets, net...........................................................................................................................................................	           52,954		  45,521
Other non-current assets...........................................................................................................................................................	         98,406		           72,473
Total assets............................................................................................................................................................	$    2,171,618		$    1,868,891
LIABILITIES AND EQUITY
Current liabilities...........................................................................................................................................................	$       457,162		$       405,989
Accounts payable......................................................................................................................................................	  198,180		         164,535
Current portion of debt, net of deferred financing fees and discounts......................................................................................................................................................	         16,064		12,775
Contract liabilities......................................................................................................................................................	66,943		     55,883
Accrued expenses and other liabilities......................................................................................................................................................	  162,474		   ; 160,367
Other current liabilities......................................................................................................................................................	     13,501		      12,429
Non-current liabilities...........................................................................................................................................................	1,052,166		    880,683
Long-term debt, net of deferred financing fees and discounts......................................................................................................................................................	    909,763		         730,430
Obligation under operating leases......................................................................................................................................................	       43,832		       37,935
Other non-current liabilities......................................................................................................................................................	         98,571		112,318
Total liabilities...........................................................................................................................................................	$    1,509,328		$    1,286,672
Shareholders’ equity
Common stock, par value $0.01: authorized 1,000,000 shares; issued 123,150 shares, outstanding 121,486 at June 30, 2022; issued 122,173 shares, outstanding 120,509 at September 30, 2021......................................................................................................................................................	$           1,232		$           1,223
Treasury stock: 1,664 shares at June 30, 2022 and 1,664 shares at September 30, 2021......................................................................................................................................................	     (2,837)		      (2,837)
Additional paid-in capital......................................................................................................................................................	      600,403		  582,052
Retained earnings (deficit)......................................................................................................................................................	       19,698		     (11,182)
Accumulated other comprehensive income, net of tax......................................................................................................................................................	     43,794		           11,415
Total Evoqua Water Technologies Corp. equity...........................................................................................................................................................	$       662,290		$       580,671
Non-controlling interest......................................................................................................................................................	                  —		          1,548
Total shareholders’ equity...........................................................................................................................................................	$       662,290		$       582,219
Total liabilities and shareholders’ equity............................................................................................................................................................	$    2,171,618		$    1,868,891

 

 

 

EVOQUA WATER TECHNOLOGIES CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CASH FLOWS (Unaudited)

(In thousands)

	Nine Months Ended June 30,
	2022		2021
Operating activities
Net income.........................................................................................................................................................	$     ;     31,025		$          24,758
Reconciliation of net income to cash flows provided by operating activities:
Depreciation and amortization....................................................................................................................................................	            93,881		  83,707
Amortization of deferred financing fees (includes $0 and $1,333 write off of deferred financing fees)....................................................................................................................................................	   1,393		          2,814
Deferred income taxes....................................................................................................................................................	          1,332		       994
Share-based compensation....................................................................................................................................................	16,339		          10,461
(Gain) loss on sale of property, plant and equipment....................................................................................................................................................	;  ;     (684)		         2,456
(Gain) loss on sale of business....................................................................................................................................................	        (193)		       ; 193
Foreign currency exchange losses (gains) on intercompany loans and other non-cash items....................................................................................................................................................	      11,235		           (4,628)
Changes in assets and liabilities....................................................................................................................................................	       (67,394)		          (17,897)
Net cash provided by operating activities............................................................................................................................................	          86,934		  102,858
Investing activities
Purchase of property, plant, and equipment...........................................................................................................................................................	     (58,700)		       (54,147)
Purchase of intangibles...........................................................................................................................................................	            (2,361)		           (1,206)
Proceeds from sale of property, plant, and equipment...........................................................................................................................................................	       2,383		     1,108
Proceeds from sale of business, net of cash of  $0 and $0...........................................................................................................................................................	       356		          897
Acquisitions, net of cash received $0 and $0 ...........................................................................................................................................................	       (206,471)		;   (21,059)
Net cash used in investing activities..............................................................................................................................................	      (264,793)		  ;       (74,407)
Financing activities
Issuance of debt, net of deferred issuance costs...........................................................................................................................................................	      245,236		;     747,877
Repayment of debt...........................................................................................................................................................	        (64,007)		;    ;   (837,082)
Repayment of finance lease obligation...........................................................................................................................................................	             (9,965)		(10,173)
Proceeds from issuance of common stock...........................................................................................................................................................	           7,921		  18,096
Taxes paid related to net share settlements of share-based compensation awards...........................................................................................................................................................	         (6,274)		            (1,315)
Distribution to non‑controlling interest...........................................................................................................................................................	               (100)		               (450)
Net cash provided by (used in) financing activities..............................................................................................................................................	          172,811		;   (83,047)
Effect of exchange rate changes on cash   .............................................................................................................................................................	     (3,357)		;            3,119
Change in cash and cash equivalents   .............................................................................................................................................................	;           (8,405)		        (51,477)
Cash and cash equivalents
Beginning of period...................................................................................................................................................	;      146,244		;        193,001
End of period...................................................................................................................................................	$        137,839		$        141,524

 

 

Use of Non-GAAP Measures

The Company reports its financial results in accordance with GAAP. However, management believes that certain non-GAAP financial measures provide users of the Company's financial information with additional useful information in evaluating operating performance. We use the non-GAAP financial measures EBITDA, adjusted EBITDA, and organic revenue in evaluating the strength and financial performance of our core business.

EBITDA and Adjusted EBITDA

EBITDA, which is a non-GAAP financial measure, is defined as net income (loss) before interest expense, income tax benefit (expense), and depreciation and amortization. Adjusted EBITDA is defined as net income (loss) before interest expense, income tax benefit (expense), and depreciation and amortization, adjusted for the impact of certain other items, including restructuring and related business transformation costs, share-based compensation, transaction costs, and other gains, losses and expenses that we believe do not directly reflect our underlying business operations.

Adjusted EBITDA is one of the primary metrics used by management to evaluate the financial performance of our business. We present adjusted EBITDA because we believe it is frequently used by analysts, investors and other interested parties to evaluate and compare operating performance and value companies within our industry. Further, we believe it is helpful in highlighting trends in our operating results and provides greater clarity and comparability period over period to management and our investors regarding the operational impact of long-term strategic decisions relating to capital structure, the tax jurisdictions in which we operate and capital investments.  In addition, adjusted EBITDA highlights true business performance by removing the impact of certain items that management believes do not directly reflect our underlying operations and provides investors with greater visibility into the ongoing organic drivers of our business performance.

 

Management uses adjusted EBITDA to supplement GAAP measures of performance as follows:

 

• to assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance;
• in our management incentive compensation, which is based in part on components of adjusted EBITDA;
• in certain calculations under our senior secured credit facilities, which use components of adjusted EBITDA;
• to evaluate the effectiveness of our business strategies;
• to make budgeting decisions; and
• to compare our performance against that of other peer companies using similar measures.

In addition to the above, our chief operating decision maker uses adjusted EBITDA of each reportable operating segment to evaluate the operating performance of such segments.  Adjusted EBITDA on a segment basis is defined as earnings before depreciation and amortization, adjusted for the impact of certain other items that have been reflected at the segment level. Adjusted EBITDA of the reportable operating segments do not include certain charges that are presented within corporate activities.  These charges include certain restructuring and other business transformation charges that have been incurred to align and reposition the Company to the current reporting structure, acquisition related costs (including transaction costs and integration costs) and share-based compensation charges.

EBITDA and Adjusted EBITDA should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. The financial results prepared in accordance with GAAP and the reconciliations from these results included below should be carefully evaluated. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. In addition, in evaluating adjusted EBITDA, you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of adjusted EBITDA. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. In addition, other companies in our industry or across different industries may calculate adjusted EBITDA differently.

The following is a reconciliation of our net income to EBITDA and adjusted EBITDA (unaudited):

	Three Months Ended June 30,						Nine Months Ended June 30,
(In millions)	2022		2021		% Variance		2022		2021		% Variance
Net income..........................................................	$          ; 17.6		$          ; 13.2		33.3 %		$              31.0		$              24.7		25.0 %
Income tax expense..........................................................	     5.0		             3.9		28.2 %		      8.9		           7.7		15.6 %
Interest expense..........................................................	;    8.4		        11.2		(25.0) %		;   25.0		       28.3		(11.7) %
Operating profit ..........................................................	$           31.0		$          ; 28.3		9.5 %		$              64.9		$              60.7		6.9 %
Depreciation and amortization..........................................................	;            32.7		       29.1		12.4 %		              93.9		     83.7		12.2 %
EBITDA..........................................................	$           63.7		$           57.4		11.0 %		$       ;     158.8		$            144.4		10.0 %
Restructuring and related business transformation costs(a)......................................................	          1.9		              1.8		5.6 %		                 5.1		;                 9.0		(43.3) %
Purchase accounting adjustment costs(b)......................................................	                1.6		               —		n/a		                  4.2		    ;              —		n/a
Share-based compensation(c)......................................................	        5.8		  5.5		5.5 %		          17.2		     11.8		45.8 %
Transaction costs(d)......................................................	             0.1		    0.3		(66.7) %		              5.0		   1.6		212.5 %
Other losses (gains) and expenses(e)......................................................	              3.9		     1.2		225.0 %		      14.2		       2.2		545.5 %
Adjusted EBITDA..........................................................	$           77.0		$           66.2		16.3 %		$            204.5		$            169.0		21.0 %

 

• Restructuring and related business transformation costs

Adjusted EBITDA is calculated prior to considering certain restructuring or business transformation events.  These events may occur over extended periods of time, and in some cases it is reasonably possible that they could reoccur in future periods based on reorganizations of the business, cost reduction or productivity improvement needs, or in response to economic conditions.  For the periods presented such events include the following:

• Certain costs and expenses in connection with various restructuring initiatives, including severance and other employee-related costs, relocation and facility consolidation costs and third-party consultant costs to assist with these initiatives. This includes:
• amounts related to the Company’s restructuring initiatives to reduce the cost structure and rationalize location footprint following the sale of the Memcor product line;
• amounts related to the Company’s transition from a three-segment structure to a two-segment operating model designed to better serve the needs of customers worldwide; and
• amounts related to various other initiatives implemented to restructure and reorganize our business with the appropriate management team and cost structure.
• Legal settlement costs and intellectual property related fees, including fees and settlement costs associated with legacy matters related to product warranty litigation on MEMCOR® products and certain discontinued products. Memcor ® is a trademark of Rohm & Haas Electronic Materials Singapore Pte. Ltd.
• Expenses associated with our information technology and functional infrastructure transformation, including activities to optimize information technology systems and functional infrastructure processes.
• Costs associated with the secondary public offering of common stock held by certain shareholders of the Company, as well as costs incurred by us in connection with establishment of our public company compliance structure and processes, including consultant costs.
• Purchase accounting adjustment costs

Adjusted EBITDA is calculated prior to considering adjustments for the effect of the purchase accounting step-up in the value of inventory to fair value recognized in cost of goods sold as a result of the acquisition of the Mar Cor Business. See Note 4, “Acquisitions,” to our Unaudited Consolidated Financial Statements included in our Quarterly Report on Form 10-Q for the three and nine months ended June 30, 2022 for further detail.

• Share-based compensation

Adjusted EBITDA is calculated prior to considering share-based compensation expenses related to equity awards. See Note 17, “Share-Based Compensation,” to our Unaudited Consolidated Financial Statements included in our Quarterly Report on Form 10-Q for the three and nine months ended June 30, 2022 for further detail.

• Transaction costs

Adjusted EBITDA is calculated prior to considering transaction, integration and restructuring costs associated with business combinations because these costs are unique to each transaction and represent costs that were incurred as a result of the transaction decision. Integration and restructuring costs associated with a business combination may occur over several years and include, but are not limited to, consulting fees, legal fees, certain employee-related costs, facility consolidation and product rationalization costs and fair value changes associated with contingent consideration.

• Other losses (gains) and expenses

Adjusted EBITDA is calculated prior to considering certain other significant losses, (gains) and expenses. For the periods presented such events include the following:

• impact of foreign exchange gains and losses;
• charges incurred by the Company related to product rationalization in its electro-chlorination business;
• amounts related to the sale of the Memcor product line;
• expenses incurred by the Company as a result of the COVID-19 pandemic, including additional charges for personal protective equipment, increased costs for facility sanitization and one-time payments to certain employees;
• legal fees incurred in excess of amounts covered by the Company’s insurance related to securities litigation and an SEC investigation; and
• loss on divestiture of the Lange product line.

 

 

Organic Revenue            

Organic revenue is another metric used by management to evaluate the performance of our business. Organic revenue is defined as revenue excluding the impact of foreign currency translation and inorganic revenue. Inorganic revenue represents the impact from acquisitions and divestitures during the first 12 months following the closing of the acquisition or divestiture. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. Management believes that reporting organic revenue provides useful information to investors by helping identify underlying growth trends in our core business and facilitating easier comparisons of our revenue performance with prior and future periods and to our peers. We exclude the effect of foreign currency translation from organic sales because foreign currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. We exclude the effect of acquisitions and divestitures during the first 12 months following the closing of the acquisition or divestiture because they can obscure underlying business trends and make comparisons of long-term performance difficult between the Company and its peers due to the varying nature, size and number of transactions from period to period.

The following is a reconciliation of total revenue to organic revenue for the three and nine months ended June 30, 2022 and 2021.

	Total Revenue				Foreign Currency				Inorganic Revenue(1)				Organic Revenue
	Three Months Ended June 30,		% Variance		Three Months Ended June 30,		% Variance		Three Months Ended June 30,		% Variance		Three Months Ended June 30,		% Variance
(In millions)	2021	2022			2021	2022			2021	2022			2021	2022
Evoqua Water Technologies.........................	$369.7	$439.3	18.8 %		n/a	$(5.3)	(1.4) %		$—	$40.8	11.0 %		$369.7	$403.8	9.2 %
Integrated Solutions & Services.........................	$239.7	$297.4	24.1 %		n/a	$(0.6)	(0.2) %		$—	$40.8	17.0 %		$239.7	$257.2	7.3 %
Applied Product Technologies.........................	$130.0	$141.9	9.2 %		n/a	$(4.7)	(3.6) %		$—	$—	— %		$130.0	$146.6	12.8 %
	Total Revenue				Foreign Currency				Inorganic Revenue(2)				Organic Revenue
	Nine Months Ended June 30,		% Variance		Nine Months Ended June 30,		% Variance		Nine Months Ended June 30,		% Variance		Nine Months Ended June 30,		% Variance
(In millions)	2021	2022			2021	2022			2021	2022			2021	2022
Evoqua Water Technologies.........................	$1,038.4	$1,232.3	18.7 %		n/a	$(6.4)	(0.6) %		$0.8	$88.7	8.5 %		$1,037.6	$1,150.0	10.8 %
Integrated Solutions & Services.........................	$678.5	$837.3	23.4 %		n/a	$(0.4)	(0.1) %		$0.8	$88.7	13.0 %		$677.7	$749.0	10.5 %
Applied Product Technologies.........................	$359.9	$395.0	9.8 %		n/a	$(6.0)	(1.6) %		$—	$—	— %		$359.9	$401.0	11.4 %

 

• Includes the acquisition of the Mar Cor Business on January 3, 2022.
• Includes divestiture of the Lange product line on March 1, 2021, acquisition of Ultrapure & Industrial Services on December 17, 2020, acquisition of WCSI on April 1, 2021, and the acquisition of the Mar Cor Business on January 3, 2022.